Back to today’s briefing

Story perspectives

PacBio's HiFi Tech Boosts Rare Disease Diagnostics

1/18/2025

48 11

Summary

Story summary

PacBio's groundbreaking HiFi long-read sequencing technology is revolutionizing the search for genetic causes of rare diseases, boasting an impressive 93% detection rate of harmful variants in a study by Radboud University Medical Center. This innovative approach could streamline diagnostics, improving both accuracy and affordability in clinical genomics, with rollout anticipated in 2025.

1 of 1

Story summary

PacBio's groundbreaking HiFi long-read sequencing technology is revolutionizing the search for genetic causes of rare diseases, boasting an impressive 93% detection rate of harmful variants in a study by Radboud University Medical Center. This innovative approach could streamline diagnostics, improving both accuracy and affordability in clinical genomics, with rollout anticipated in 2025.